Latest News
Thursday October 2, 2008 — Clarient, Inc.; WallStreet Direct, Inc.
ALISO VIEJO, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the company's CEO, Ronald Andrews, is featured in an exclusive interview ...
Tuesday July 1, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., July 1 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced its new offering, KRAS, which has been validated as a laboratory-developed te...
Thursday May 29, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., May 29 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that, effective June 5th, veteran financial executive Raymond J. Land, 63, wil...
Thursday May 22, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., May 22 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that its Senior Vice President and Chief Financial Officer, Jim Agnello, will ...
Tuesday May 6, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has signed a one-year agreement with Joint Venture Hospital Laboratorie...
Thursday May 1, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., April 30 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced preliminary financial results for the first quarter ended March 31, 2008. Re...
Tuesday April 29, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., April 28 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Michael J. Pellini, M.D. has resigned from his position of Vice President of the Life Sciences Gr...
Monday March 31, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., March 31 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced financial results for the fourth quarter and year ended December 31, 2007. Revenue from continuing ope...
Friday March 28, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., March 27 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor presentation at the B. Riley Co. 9th Annual Las Vegas Invest...
Thursday January 31, 2008 — CombiMatrix Corporation; Clarient, Inc.
MUKILTEO, Wash. and ALISO VIEJO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CombiMatrix Corporation and Clarient, Inc. today jointly announced establishment of a strategic partnership to market and sell a novel genomics-based cancer test called HemeScan(TM), a comprehensive test related to the t...
Thursday January 10, 2008 — Clarient
ALISO VIEJO, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it will commercialize a novel breast cancer test, the first molecular test available that is applic...
Monday January 7, 2008 — Clarient, Inc.
ALISO VIEJO, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that CEO Ron Andrews is scheduled to participate in the OneMedPlace Emerging Healthcare Technologies Fin...